Extended Spectrum Antibiotics

"Extended-spectrum antibiotics" is a descriptive pharmacological category rather than a formal, distinct regulatory drug class, referring to antimicrobial agents chemically modified from narrow-spectrum parent compounds to broaden their activity against additional bacterial species, particularly gram-negative organisms Functioning primarily by targeting vital bacterial processes such as peptidoglycan cell wall biosynthesis or protein synthesis, these agents—most notably extended-spectrum penicil...

Functioning primarily by targeting vital bacterial processes such as peptidoglycan cell wall biosynthesis or protein synthesis, these agents—most notably extended-spectrum penicillins and advanced-generation cephalosporins—provide empiric and targeted antimicrobial coverage

Functioning primarily by targeting vital bacterial processes such as peptidoglycan cell wall biosynthesis or protein synthesis, these agents—most notably extended-spectrum penicillins and advanced-generation cephalosporins—provide empiric and targeted antimicrobial coverage

Clinically, they are deployed to manage moderate to severe infectious diseases, including complicated urinary tract infections, intra-abdominal infections, hospital-acquired and community-acquired pneumonia, and systemic bloodstream infections

Clinically, they are deployed to manage moderate to severe infectious diseases, including complicated urinary tract infections, intra-abdominal infections, hospital-acquired and community-acquired pneumonia, and systemic bloodstream infections

Clinically, they are deployed to manage moderate to severe infectious diseases, including complicated urinary tract infections, intra-abdominal infections, hospital-acquired and community-acquired pneumonia, and systemic bloodstream infections